{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-018848","form_type":"8-K","ticker":"BVS","cik":"0001665988","company_name":"Bioventus Inc.","filed_at":"2022-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.588480+00:00","generated_at":"2026-06-24T16:48:06.721946+00:00","sec_items":["1.01","2.01","2.03","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bioventus closes CartiHeal acquisition for $315M upfront; $80M term loan funded","bullets":["Acquired CartiHeal for ~$315M upfront plus up to $135M in sales milestone earn-outs.","Acquisition closed July 12, 2022; $100M paid at closing, $215M deferred in tranches through 2027.","Funded part of purchase with $80M term loan (2022-1 Term Loans) maturing Oct 29, 2026.","Term loan bears interest at SOFR + 3.25% or Base Rate + 2.25% with leverage-based margins.","Credit agreement amended; financial covenants include max leverage 4.75x and min interest coverage 2.25x."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-018848","json":"https://secwatch.observer/filing/0001628280-22-018848.json","markdown":"https://secwatch.observer/filing/0001628280-22-018848.md","text":"https://secwatch.observer/filing/0001628280-22-018848.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1665988/000162828022018848/0001628280-22-018848-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1665988/000162828022018848/bvs-20220712.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T16:48:06.721946+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}